Research.Patient.info
Non Small Cell Lung Cancer research hub
2 indexed studies · 1 currently recruiting
- recruitingNA
A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
This study looks at lung cancer patients with specific gene changes (EGFR mutations) who have had surgery. Researchers want to understand why some cancers return after a targeted treatment called osimertinib and how to find the best future treatments if needed.
France - active not recruitingPHASE3
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
This study looks at a new drug, patritumab deruxtecan, for a type of lung cancer that has stopped responding to standard treatments. It compares this new drug with traditional chemotherapy to see if it works better and is safer for patients.
United States · Australia · Austria